ORIGINAL RESEARCH article
Front. Immunol.
Sec. Viral Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1567306
This article is part of the Research TopicHost Dynamics and Immune Evasion: Delineating the Influence of RNA and DNA VirusesView all 5 articles
Dynamic Alterations of Circulating Lymphocytes during the Trajectory of Hantaan Virus-induced Hemorrhagic Fever with Renal Syndrome
Provisionally accepted- 1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
- 2Weinan Central Hospital, Weinan, Shanxi, China
- 3Xi'an Jiaotong University, Xi'an, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Hemorrhagic fever with renal syndrome (HFRS) is a zoonotic disease with high mortality. Almost 90% of global cases of HFRS are induced by Hantaan virus (HTNV) infection. Although lymphocyte dysfunction is a critical factor in HFRS progression, the specific immune dynamics of HTNV remain unexplored, and current analyses predominantly depend on single-timepoint sampling. Here, we performed longitudinal profiling of circulating lymphocytes in 39 HTNV-HFRS patients across different clinical phases, revealing phase-specific immune patterns: CD8 + T, CD8 + Tems, and activated CD8 + T, MAIT and NKT cells peaked during febrile/oliguric phases before declining in polyuria/recovery, while CD4 + T and MAIT cells showed inverse fluctuation patterns. Higher frequencies of CD8 + Tem, B, and CD56 dim NK cells during the febrile phase correlated with severe disease, enabling early risk stratification. Lower CD4 + Tcm levels in the oliguric phase marked progression to severe HFRS, indicating potential therapeutic strategies aimed at enhancing CD4 + Tcm generation or inhibiting effector differentiation. Additionally, CD38 and CD161 expression predicted specific lymphocyte subset dynamics, offering novel biomarkers for immunomodulatory strategies. Our study thus provides the first comprehensive atlas of lymphocyte evolution in HTNV-induced HFRS, connecting immune dysregulation with clinical outcomes.
Keywords: Dynamic alterations, Lymphocyte Subsets, biomarkers, HTNV, HFRS
Received: 27 Jan 2025; Accepted: 05 May 2025.
Copyright: © 2025 Li, Su, Liu, Shi, Cheng, Gao, Guo, He, Zhang, Chen, Hu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiaojiao Li, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.